KCAS Bio is a leading bioanalytical contract research organization (CRO) with 45+ years of experience. Supported 315+ approved drugs on market, developed 6,200+ assays. Services include bioanalytical development, biomarker analysis, immunogenicity testing, cellular and molecular assays, clinical kitting and sample management. Specializes in advanced modalities (cell therapy, gene therapy). Globally harmonized Cytek spectral flow cytometry across US, EU, and Australia sites. 20+ FDA audits with no major findings.
3 sites worldwide
No certifications on file yet.
No reviews available yet.
No documents available.